Preterm Infants Can Mount Appropriate C-Reactive Protein Responses to Early Onset Sepsis

Sanket D Shah1, Ajay J Talati1, Mohamad T Elabiad1

  • 1Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee.

Insights

Infants born at or before 32 weeks gestational age (GA) show C-reactive protein (CRP) responses to bacterial sepsis comparable to those born after 32 weeks GA. This finding suggests similar inflammatory responses in both groups during early sepsis.

Area of Science:

  • Neonatal Medicine
  • Pediatric Infectious Diseases
  • Biomarkers in Neonatal Sepsis

Background:

  • Early onset bacterial sepsis is a significant concern in neonates.
  • Gestational age (GA) is a critical factor influencing neonatal health outcomes.
  • C-reactive protein (CRP) is a key inflammatory marker used in sepsis diagnosis.

Purpose of the Study:

  • To compare C-reactive protein (CRP) responses in early-onset bacterial sepsis between preterm infants (≤32 weeks GA) and term infants (>32 weeks GA).
  • To determine if gestational age impacts the ability to mount a CRP response to sepsis.

Main Methods:

  • Retrospective analysis of infants with positive bacterial cultures within 72 hours of birth (2003-2012).
  • Infants were categorized into two groups based on gestational age: ≤32 weeks (Group A) and >32 weeks (Group B).
  • CRP levels were analyzed to compare responses between and within groups over time.

Main Results:

  • Group A comprised 25 infants, and Group B included 122 infants.
  • Both groups exhibited similar CRP responses to sepsis (p=0.59), with significant intragroup changes over time (p<0.0001).
  • The rate of CRP change over time was comparable between the two gestational age groups (p=0.74).

Conclusions:

  • Infants born at ≤32 weeks GA demonstrate CRP responses to bacterial sepsis that are comparable to those born at >32 weeks GA.
  • The findings suggest that preterm infants can mount an inflammatory response to sepsis similar to their term counterparts.
  • CRP is a reliable biomarker for assessing sepsis in both preterm and term neonates.
Abstract